| Cart Total:
Menu
Progress Report: August 2022
  • Manufacturing, Quality, Service

Progress Report: August 2022

Publication:
Quality Progress
Date:
August 2022
Issue:
Volume 55 Issue 8
Pages:
pp. 6-9
Author(s):
QP Staff
Organization(s):
ASQ, Milwaukee, WI

Abstract

The U.S. Food and Drug Administration releases new risk management guidance for drug manufacturers. Plus, the Baldrige Process is paused while the program's organizers and leaders “engage in a comprehensive external program review that builds on our own change initiatives.” 

ALREADY A MEMBER?    REGISTER